Nivolumab improved survival vs dacarbazine in patients with untreated advanced melanoma

Date 05 December 2014
Event Melanoma Bridge 2014
Session News in immunotherapy
Topics Cancer Immunology and Immunotherapy
Melanoma and other Skin Tumours
Presenter Paolo A. Ascierto